Back to Search
Start Over
Systemic Sarcoidosis Associated with Certolizumab Pegol Treatment for Rheumatoid Arthritis: A Case Report and Review of the Literature.
- Source :
-
Internal medicine (Tokyo, Japan) [Intern Med] 2020 Aug 15; Vol. 59 (16), pp. 2015-2021. Date of Electronic Publication: 2020 May 08. - Publication Year :
- 2020
-
Abstract
- A 69-year-old woman presented with appetite loss, fatigue, and a low-grade fever. She had been receiving certolizumab pegol for rheumatoid arthritis for six years. Computed tomography of the chest showed multiple micronodules in both lungs and bilateral hilar and mediastinal lymphadenopathy. An ophthalmic examination showed the findings of uveitis. Lymphocytosis with an increased CD4/CD8 ratio was seen in the bronchoalveolar lavage fluid. Video-assisted thoracoscopic biopsy specimens obtained from the right lung and a right hilar lymph node showed noncaseous epithelioid cell granulomas. Anti-tumor necrosis factor-α-induced sarcoidosis was diagnosed, and she was successfully treated with cessation of certolizumab pegol and systemic corticosteroid therapy.
- Subjects :
- Aged
Bronchoalveolar Lavage Fluid cytology
Certolizumab Pegol therapeutic use
Female
Granuloma pathology
Humans
Lung pathology
Lymph Nodes pathology
Lymphocytosis etiology
Mediastinum pathology
Tomography, X-Ray Computed
Uveitis etiology
Arthritis, Rheumatoid drug therapy
Certolizumab Pegol adverse effects
Sarcoidosis etiology
Subjects
Details
- Language :
- English
- ISSN :
- 1349-7235
- Volume :
- 59
- Issue :
- 16
- Database :
- MEDLINE
- Journal :
- Internal medicine (Tokyo, Japan)
- Publication Type :
- Academic Journal
- Accession number :
- 32389943
- Full Text :
- https://doi.org/10.2169/internalmedicine.4275-19